In this piece we will take a look at the top five healthcare stocks to buy today according to Steven Cohen's Point72 Asset Management. If you want to learn about Mr.
Keep Reading →
March 22 - News
Hedge Funds and other institutional investors have just completed filing their 13Fs with the Securities and Exchange Commission, revealing their equity portfolios as of the end...
Keep Reading →
December 17 - Hedge Funds, News
In this piece, we will take a look at the 5 biotech and pharma stocks to buy according to billionaire Steve Cohen. If you want to check out more stocks and learn about Mr.
Keep Reading →
November 29 - Hedge Funds, News
Dalton Investments, a $3.4 billion U.S. investment firm, says it’s still on the fence over whether to support Shinsei Bank Ltd.’s management or SBI Holdings Inc.
Keep Reading →
November 18 - Hedge Funds, Insider Trading
In this article, we discuss Tesla and the 4 other stocks that Cathie Wood is selling.
Keep Reading →
November 17 - Hedge Funds, News
In this article, we will take a look at the 11 best genomic stocks to buy now.
Keep Reading →
October 19 - Hedge Funds, News
We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy...
Keep Reading →
October 12 - Hedge Funds, News
In this article, we discuss the 10 stocks Cathie Wood is getting rid of.
Keep Reading →
August 24 - Hedge Funds, News
Out of thousands of stocks that are currently traded on the market, it is difficult to identify those that will really generate strong returns.
Keep Reading →
July 6 - Hedge Funds, News
Artisan Partners, a high value-added investment management firm, published its ‘Artisan Mid Cap Fund’ first quarter 2021 investor letter – a copy of which can be downloaded...
Keep Reading →
May 7 - Hedge Fund Investor Letters, News
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Keep Reading →
April 7 - Hedge Funds, News
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the...
Keep Reading →
December 20 - Hedge Funds, News
Biotech companies are research science-driven companies focusing on novel drug development and clinical research with aims to treat diseases and medical conditions.
Keep Reading →
December 17 - ETF Trading, Hedge Funds, News, Tech
We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy...
Keep Reading →
November 6 - Hedge Funds, News
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Keep Reading →
September 8 - Hedge Funds, News
We know that hedge funds generate strong, risk-adjusted returns over the long run, which is why imitating the picks that they are collectively bullish on can be a profitable strategy...
Keep Reading →
July 10 - Hedge Funds, News
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Keep Reading →
June 2 - Hedge Funds, News
Coronavirus is probably the #1 concern in investors’ minds right now. It should be.
Keep Reading →
March 11 - Hedge Funds, News
Hedge funds and other investment firms that we track manage billions of dollars of their wealthy clients' money, and needless to say, they are painstakingly thorough when analyzing...
Keep Reading →
December 26 - Hedge Funds, News
Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 750 active prominent money ...
Keep Reading →
December 4 - Hedge Funds, News
Is Sarepta Therapeutics Inc (NASDAQ:SRPT) a good investment right now? We check hedge fund and billionaire investor sentiment before delving into hours of research.
Keep Reading →
October 12 - Hedge Funds, News
Is Sarepta Therapeutics Inc (NASDAQ:SRPT) a good investment right now? We check hedge fund and billionaire investor sentiment before delving into hours of research.
Keep Reading →
June 10 - Hedge Funds, News
We at Insider Monkey have gone over 700 13F filings that hedge funds and prominent investors are required to file by the SEC.
Keep Reading →
April 19 - Hedge Funds, News
Hedge funds and other investment firms run by legendary investors like Israel Englander and Ray Dalio are entrusted to manage billions of dollars of accredited investors' money...
Keep Reading →
December 8 - Hedge Funds, News
It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the end of the day, these asset...
Keep Reading →
November 6 - Hedge Funds, News
Insider purchases consistently outpaced insider sales during much of October, the first time that has happened over a minimum two-week period since January 2016.
Keep Reading →
November 4 - Insider Trading, News
"U.S. stocks traded firmly higher Wednesday, with the Nasdaq Composite setting an intraday record, after a strong reading on private-sector hiring in March.
Keep Reading →
April 5 - Commodities, Gold, Market Movers, News, Tech
Sarepta Therapeutics Inc (NASDAQ:SRPT) shares have popped 4% after Edward Nash of SunTrust upgraded the equity to 'Buy' from 'Hold' and set a $45 target price.
Keep Reading →
April 5 - Market Movers, News
In a rather quiet market where the Dow is down but the S&P and NASDAQ are both up, Sarepta Therapeutics Inc (NASDAQ:SRPT) shares have rallied 3%, showing some solid relative...
Keep Reading →
March 22 - News
Sarepta Therapeutics Inc (NASDAQ:SRPT) is one of the week’s biggest winners from the J.P.
Keep Reading →
January 11 - News, Stock Analysis
It is already common knowledge that individual investors do not usually have the necessary resources and abilities to properly research an investment opportunity.
Keep Reading →
December 7 - Hedge Funds, News
The medical sector is growing rapidly and getting in on the ground floor with med tech can be highly profitable for smart investors, but how can you know which stocks to choose...
Keep Reading →
December 1 - News, Stock Analysis
Joseph Edelman's Perceptive Advisors is a fund that has an equity portfolio worth $1.44 billion as of the end of June, with over 80% of it being invested in healthcare stocks.
Keep Reading →
November 8 - Hedge Funds, News
Jason Karp's Tourbillon Capital Partners has retaken a stake in Sarepta Therapeutics Inc (NASDAQ:SRPT) after having sold off its previous position in the stock during the second...
Keep Reading →
October 28 - Hedge Funds, Market Movers, News
If you follow Sarepta Therapeutics Inc (NASDAQ:SRPT), you know about Eteplirsen. The treatment is designed to treat several diseases, including Duchenne muscular dystrophy.
Keep Reading →
October 19 - News
After yesterday's rather sharp fall, Wall Street is quiet today as the Dow is up only 14 points while the NASDAQ is 0.01% in the green. In this article, we analyze some stocks...
Keep Reading →
October 12 - Market Movers, News
WTI crude futures have sank below the $50 per barrel mark around noon as traders brace for another potential rise in the rig count.
Keep Reading →
October 7 - News
Broad markets are shaky today with NASDAQ trading in red territory.
Keep Reading →
September 28 - Market Movers, News
With the U.S.
Keep Reading →
September 26 - Market Movers, News
Wall Street is quiet today after the Federal Reserve's Wednesday decision of keeping interest rates the same.
Keep Reading →
September 22 - Earnings Report, Market Movers, News
Among the stocks capturing attention from traders early this morning are SeaWorld Entertainment Inc (NYSE:SEAS), Ascena Retail Group Inc (NASDAQ:ASNA), Wal-Mart Stores, Inc.
Keep Reading →
September 20 - Market Movers, News
Wall Street is in bull mode today as all three major indexes are in the green, with the Dow rising 90 points, the S&P 500 increasing 0.5% and the NASDAQ inching up 0.4%.
Keep Reading →
September 19 - Market Movers, News
Some stocks are nonetheless gaining ground this morning, including Sarepta Therapeutics Inc (NASDAQ:SRPT), At Home Group Inc.
Keep Reading →
September 14 - Market Movers, News
Duchenne’s Muscular Dystrophy (DMD) is a hot topic right now.
Keep Reading →
June 21 - News, Stock Analysis
The markets are in the green ahead of Tuesday's opening bell, with the S&P, Nasdaq, and Dow futures are all in positive territory, as are crude futures.
Keep Reading →
June 7 - Market Movers, News
The markets have been quiet so far today, amid news involving the ADP private payrolls rising by 173,000 for May and OPEC agreeing to maintain the status quo.
Keep Reading →
June 2 - Market Movers, News
Sarepta Therapeutics Inc (NASDAQ:SRPT) is up by 16% this morning after the FDA informed the company that it needs additional time to complete the review of the New Drug Application...
Keep Reading →
May 25 - Hedge Funds, Market Movers, News
Even though oil is down on Monday, U.S stocks are up, partly driven by strength in the financial and consumer discretionary sectors.
Keep Reading →
May 2 - Market Movers, News
